Neurocrine Bio. (NBIX) PT Raised to $119 at Mizuho Securities
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $131.50 -0.78%
Rating Summary:
24 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
24 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Mizuho Securities analyst Vamil Divan raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $119.00 (from $117.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Alpine Income Property Trust (PINE) PT Lowered to $18 at Jones Trading
- Uber Inc. (UBER) PT Raised to $96 at Tigress Financial Partners
- Johnson Matthey PLC (JMAT:LN) (JMPLY) PT Raised to GBP21.70 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
